ID: ALA274908

Max Phase: Preclinical

Molecular Formula: C14H16ClNO

Molecular Weight: 249.74

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  [O-][N+]1=Cc2cc(Cl)ccc2CC12CCCCC2

Standard InChI:  InChI=1S/C14H16ClNO/c15-13-5-4-11-9-14(6-2-1-3-7-14)16(17)10-12(11)8-13/h4-5,8,10H,1-3,6-7,9H2

Standard InChI Key:  KYFIGHHKMVEDPA-UHFFFAOYSA-N

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 249.74Molecular Weight (Monoisotopic): 249.0920AlogP: 3.53#Rotatable Bonds: 0
Polar Surface Area: 26.07Molecular Species: ACIDHBA: 1HBD: 0
#RO5 Violations: 0HBA (Lipinski): 2HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: 1.23CX Basic pKa: CX LogP: 0.87CX LogD: 2.89
Aromatic Rings: 1Heavy Atoms: 17QED Weighted: 0.51Np Likeness Score: 0.05

References

1. Bernotas RC, Thomas CE, Carr AA, Nieduzak TR, Adams G, Ohlweiler DF, Hay DA.  (1996)  Synthesis and radical scavenging activity of 3,3-dialkyl-3,4-dihydro-isoquinoline 2-oxides,  (10): [10.1016/0960-894X(96)00181-3]

Source